Clinical Trials · NCT01476475

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Name: Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Lixisenatide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Sanofi
Enrollment: 323
Start date: Nov 2011
Locations: 70 sites, 13 countries
Primary endpoint: Change in HbA1c From Baseline to Week 24

View Lixisenatide compound reference